Alzheimer’s cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alzheimer’s cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-12
DOI
10.1186/s13195-020-00767-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concordance of Lumipulse cerebrospinal fluid t-tau/Aβ42 ratio with amyloid PET status
- (2020) June Kaplow et al. Alzheimers & Dementia
- Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis
- (2020) Luisa Agnello et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples
- (2019) Steffen Wolfsgruber et al. Alzheimers Research & Therapy
- Assessment of Racial Disparities in Biomarkers for Alzheimer Disease
- (2019) John C. Morris et al. JAMA Neurology
- Clinical and Biomarker Characteristics According to Clinical Spectrum of Alzheimer’s Disease (AD) in the Validation Cohort of Korean Brain Aging Study for the Early Diagnosis and Prediction of AD
- (2019) Jihye Hwang et al. Journal of Clinical Medicine
- Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ42 and T-Tau assays for Alzheimer’s disease diagnosis
- (2019) Jean-Louis Bayart et al. JOURNAL OF NEUROLOGY
- Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
- (2019) Daniel Alcolea et al. Annals of Clinical and Translational Neurology
- Idiopathic pulmonary arterial hypertension associated with a novel frameshift mutation in the bone morphogenetic protein receptor II gene and enhanced bone morphogenetic protein signaling
- (2019) Sun Ha Choi et al. MEDICINE
- Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease
- (2019) Maria João Leitão et al. Alzheimers Research & Therapy
- The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- Biomarkers for Alzheimer's disease: current status and prospects for the future
- (2018) K. Blennow et al. JOURNAL OF INTERNAL MEDICINE
- Brachial-Ankle Pulse Wave Velocity and the Risk Prediction of Cardiovascular DiseaseNovelty and Significance
- (2017) Toshiaki Ohkuma et al. HYPERTENSION
- Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment
- (2017) Shorena Janelidze et al. JAMA Neurology
- Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid
- (2016) Tobias Bittner et al. Alzheimers & Dementia
- Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements
- (2016) Maria Bjerke et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Prevalence of Amyloid PET Positivity in Dementia Syndromes
- (2015) Rik Ossenkoppele et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Use of amyloid-PET to determine cutpoints for CSF markers
- (2015) Marissa D. Zwan et al. NEUROLOGY
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Inter-laboratory variation when using a unified test procedure for INNO-BIA AlzBio3
- (2013) Manu Vandijck et al. Alzheimers & Dementia
- CSF biomarker variability in the Alzheimer's Association quality control program
- (2013) Niklas Mattsson et al. Alzheimers & Dementia
- Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid- 1-42 and Proteins as Alzheimer Disease Biomarkers
- (2013) J.-H. Kang et al. CLINICAL CHEMISTRY
- Practical utility of amyloid and FDG-PET in an academic dementia center
- (2013) P. Sanchez-Juan et al. NEUROLOGY
- Impact of molecular imaging on the diagnostic process in a memory clinic
- (2012) Rik Ossenkoppele et al. Alzheimers & Dementia
- Comparison of Cerebrospinal Fluid Levels of Tau and Aβ 1-42 in Alzheimer Disease and Frontotemporal Degeneration Using 2 Analytical Platforms
- (2012) David J. Irwin et al. ARCHIVES OF NEUROLOGY
- Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer’s disease
- (2012) Ju-Hee Kang et al. METHODS
- Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI
- (2011) Leslie M. Shaw et al. ACTA NEUROPATHOLOGICA
- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
- (2011) Niklas Mattsson et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology
- (2011) Anne M. Fagan ARCHIVES OF NEUROLOGY
- Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia
- (2011) William E. Klunk NEUROBIOLOGY OF AGING
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
- (2009) C. Mulder et al. CLINICAL CHEMISTRY
- Development of the Subjective Memory Complaints Questionnaire
- (2009) Jong Chul Youn et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
- (2008) Clifford R. Jack et al. BRAIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now